Literature DB >> 22436981

Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium.

Michele L Coté1, Mei Liu, Stefano Bonassi, Monica Neri, Ann G Schwartz, David C Christiani, Margaret R Spitz, Joshua E Muscat, Gad Rennert, Katja K Aben, Angeline S Andrew, Vladimir Bencko, Heike Bickeböller, Paolo Boffetta, Paul Brennan, Hermann Brenner, Eric J Duell, Eleonora Fabianova, John K Field, Lenka Foretova, Søren Friis, Curtis C Harris, Ivana Holcatova, Yun-Chul Hong, Dolores Isla, Vladimir Janout, Lambertus A Kiemeney, Chikako Kiyohara, Qing Lan, Philip Lazarus, Jolanta Lissowska, Loic Le Marchand, Dana Mates, Keitaro Matsuo, Jose I Mayordomo, John R McLaughlin, Hal Morgenstern, Heiko Müeller, Irene Orlow, Bernard J Park, Mila Pinchev, Olaide Y Raji, Hedy S Rennert, Peter Rudnai, Adeline Seow, Isabelle Stucker, Neonila Szeszenia-Dabrowska, M Dawn Teare, Anne Tjønnelan, Donatella Ugolini, Henricus F M van der Heijden, Erich Wichmann, John K Wiencke, Penella J Woll, Ping Yang, David Zaridze, Zuo-Feng Zhang, Carol J Etzel, Rayjean J Hung.   

Abstract

BACKGROUND AND METHODS: Familial aggregation of lung cancer exists after accounting for cigarette smoking. However, the extent to which family history affects risk by smoking status, histology, relative type and ethnicity is not well described. This pooled analysis included 24 case-control studies in the International Lung Cancer Consortium. Each study collected age of onset/interview, gender, race/ethnicity, cigarette smoking, histology and first-degree family history of lung cancer. Data from 24,380 lung cancer cases and 23,305 healthy controls were analysed. Unconditional logistic regression models and generalised estimating equations were used to estimate odds ratios and 95% confidence intervals.
RESULTS: Individuals with a first-degree relative with lung cancer had a 1.51-fold increase in the risk of lung cancer, after adjustment for smoking and other potential confounders (95% CI: 1.39, 1.63). The association was strongest for those with a family history in a sibling, after adjustment (odds ratios (OR) = 1.82, 95% CI: 1.62, 2.05). No modifying effect by histologic type was found. Never smokers showed a lower association with positive familial history of lung cancer (OR = 1.25, 95% CI: 1.03, 1.52), slightly stronger for those with an affected sibling (OR = 1.44, 95% CI: 1.07, 1.93), after adjustment.
CONCLUSIONS: The occurrence of lung cancer among never smokers and similar magnitudes of the effect of family history on lung cancer risk across histological types suggests familial aggregation of lung cancer is independent of those risks associated with cigarette smoking. While the role of genetic variation in the aetiology of lung cancer remains to be fully characterised, family history assessment is immediately available and those with a positive history represent a higher risk group.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22436981      PMCID: PMC3445438          DOI: 10.1016/j.ejca.2012.01.038

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  70 in total

1.  Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population.

Authors:  M A Loriot; S Rebuissou; M Oscarson; S Cenée; M Miyamoto; N Ariyoshi; T Kamataki; D Hémon; P Beaune; I Stücker
Journal:  Pharmacogenetics       Date:  2001-02

2.  Cancer aggregation and complex segregation analysis of families with female non-smoking lung cancer probands in Taiwan.

Authors:  P-F Wu; C-H Lee; M-J Wang; W B Goggins; T-A Chiang; M-S Huang; Y-C Ko
Journal:  Eur J Cancer       Date:  2004-01       Impact factor: 9.162

3.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

4.  Familial cancers in a nationwide family cancer database: age distribution and prevalence.

Authors:  K Hemminki; P Vaittinen
Journal:  Eur J Cancer       Date:  1999-07       Impact factor: 9.162

5.  Cystic fibrosis transmembrane conductance regulator gene mutation and lung cancer risk.

Authors:  Yafei Li; Zhifu Sun; Yanhong Wu; Dusica Babovic-Vuksanovic; Yan Li; Julie M Cunningham; Vernon S Pankratz; Ping Yang
Journal:  Lung Cancer       Date:  2010-02-08       Impact factor: 5.705

6.  Risk of lung cancer among white and black relatives of individuals with early-onset lung cancer.

Authors:  Michele L Coté; Sharon L R Kardia; Angela S Wenzlaff; John C Ruckdeschel; Ann G Schwartz
Journal:  JAMA       Date:  2005-06-22       Impact factor: 56.272

7.  Comparison of discriminatory power and accuracy of three lung cancer risk models.

Authors:  A M D'Amelio; A Cassidy; K Asomaning; O Y Raji; S W Duffy; J K Field; M R Spitz; D Christiani; C J Etzel
Journal:  Br J Cancer       Date:  2010-06-29       Impact factor: 7.640

8.  Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer.

Authors:  Pengyuan Liu; Haris G Vikis; Daolong Wang; Yan Lu; Yian Wang; Ann G Schwartz; Susan M Pinney; Ping Yang; Mariza de Andrade; Gloria M Petersen; Jonathan S Wiest; Pamela R Fain; Adi Gazdar; Colette Gaba; Henry Rothschild; Diptasri Mandal; Teresa Coons; Juwon Lee; Elena Kupert; Daniela Seminara; John Minna; Joan E Bailey-Wilson; Xifeng Wu; Margaret R Spitz; Timothy Eisen; Richard S Houlston; Christopher I Amos; Marshall W Anderson; Ming You
Journal:  J Natl Cancer Inst       Date:  2008-09-09       Impact factor: 13.506

9.  Lung carcinoma in former smokers.

Authors:  L Tong; M R Spitz; J J Fueger; C A Amos
Journal:  Cancer       Date:  1996-09-01       Impact factor: 6.860

10.  Lung cancer in a U.S. population with low to moderate arsenic exposure.

Authors:  Julia E Heck; Angeline S Andrew; Tracy Onega; James R Rigas; Brian P Jackson; Margaret R Karagas; Eric J Duell
Journal:  Environ Health Perspect       Date:  2009-07-02       Impact factor: 9.031

View more
  53 in total

1.  Informed genome-wide association analysis with family history as a secondary phenotype identifies novel loci of lung cancer.

Authors:  Julia G Poirier; Paul Brennan; James D McKay; Margaret R Spitz; Heike Bickeböller; Angela Risch; Geoffrey Liu; Loic Le Marchand; Shelley Tworoger; John McLaughlin; Albert Rosenberger; Joachim Heinrich; Irene Brüske; Thomas Muley; Brian E Henderson; Lynne R Wilkens; Xuchen Zong; Yafang Li; Ke Hao; Wim Timens; Yohan Bossé; Don D Sin; Ma'en Obeidat; Christopher I Amos; Rayjean J Hung
Journal:  Genet Epidemiol       Date:  2015-01-19       Impact factor: 2.135

Review 2.  Screening for lung cancer using low-dose computed tomography: concerns about the application in low-risk individuals.

Authors:  Jiu-Wei Cui; Wei Li; Fu-Jun Han; Yu-Di Liu
Journal:  Transl Lung Cancer Res       Date:  2015-06

3.  Genetic variant in DNA repair gene GTF2H4 is associated with lung cancer risk: a large-scale analysis of six published GWAS datasets in the TRICL consortium.

Authors:  Meilin Wang; Hongliang Liu; Zhensheng Liu; Xiaohua Yi; Heike Bickeboller; Rayjean J Hung; Paul Brennan; Maria Teresa Landi; Neil Caporaso; David C Christiani; Jennifer Anne Doherty; Christopher I Amos; Qingyi Wei
Journal:  Carcinogenesis       Date:  2016-06-10       Impact factor: 4.944

Review 4.  Lung cancer health disparities.

Authors:  Bríd M Ryan
Journal:  Carcinogenesis       Date:  2018-05-28       Impact factor: 4.944

5.  Epidemiology in Germany-general development and personal experience.

Authors:  Heinz-Erich Wichmann
Journal:  Eur J Epidemiol       Date:  2017-08-16       Impact factor: 8.082

6.  Family history of lung cancer in never smokers with non-small-cell lung cancer and its association with tumors harboring EGFR mutations.

Authors:  Elizabeth M Gaughan; Sarah K Cryer; Beow Y Yeap; David M Jackman; Daniel B Costa
Journal:  Lung Cancer       Date:  2012-12-27       Impact factor: 5.705

7.  The heritability of prostate cancer in the Nordic Twin Study of Cancer.

Authors:  Jacob B Hjelmborg; Thomas Scheike; Klaus Holst; Axel Skytthe; Kathryn L Penney; Rebecca E Graff; Eero Pukkala; Kaare Christensen; Hans-Olov Adami; Niels V Holm; Elizabeth Nuttall; Steinbjorn Hansen; Mikael Hartman; Kamila Czene; Jennifer R Harris; Jaakko Kaprio; Lorelei A Mucci
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-05-08       Impact factor: 4.254

8.  Predictive Accuracy of the PanCan Lung Cancer Risk Prediction Model -External Validation based on CT from the Danish Lung Cancer Screening Trial.

Authors:  Mathilde M Winkler Wille; Sarah J van Riel; Zaigham Saghir; Asger Dirksen; Jesper Holst Pedersen; Colin Jacobs; Laura Hohwü Thomsen; Ernst Th Scholten; Lene T Skovgaard; Bram van Ginneken
Journal:  Eur Radiol       Date:  2015-03-13       Impact factor: 5.315

9.  Understanding the role of family dynamics, perceived norms, and lung cancer worry in predicting second-hand smoke avoidance among high-risk lung cancer families.

Authors:  Mark Manning; Mark Wojda; Lauren Hamel; Alicia Salkowski; Ann G Schwartz; Felicity Wk Harper
Journal:  J Health Psychol       Date:  2016-03-07

10.  Familial Risk and Heritability of Cancer Among Twins in Nordic Countries.

Authors:  Lorelei A Mucci; Jacob B Hjelmborg; Jennifer R Harris; Kamila Czene; David J Havelick; Thomas Scheike; Rebecca E Graff; Klaus Holst; Sören Möller; Robert H Unger; Christina McIntosh; Elizabeth Nuttall; Ingunn Brandt; Kathryn L Penney; Mikael Hartman; Peter Kraft; Giovanni Parmigiani; Kaare Christensen; Markku Koskenvuo; Niels V Holm; Kauko Heikkilä; Eero Pukkala; Axel Skytthe; Hans-Olov Adami; Jaakko Kaprio
Journal:  JAMA       Date:  2016-01-05       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.